SCHEMBL12656154

SCHEMBL12656154

CC(Oc1cc(Cl)ccc1Cl)C(N)=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.50
HTR2A P28223 1/20 0.50
HTR2C P28335 1/20 0.50
HTR2B P41595 1/20 0.50
SMN1; SMN2 Q16637 3/20 0.48
LMNA P02545 3/20 0.46
HPGD P15428 2/20 0.46
ALOX12 P18054 2/20 0.46
CYP1A2 P05177 1/20 0.46
GLA P06280 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
GAA P10253 3/20 0.45
PTGDR2 Q9Y5Y4 2/20 0.45
KDM4E B2RXH2 2/20 0.45
ALDH1A1 P00352 2/20 0.45
PTGDR Q13258 1/20 0.45
NOS2 P35228 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4164467 0.87 SMN1; SMN2 (0.62) TSHRHTR2AHTR2CHTR2BSMN1; SMN2
SCHEMBL21056089 0.87 SMN1; SMN2 (0.62) TSHRHTR2AHTR2CHTR2BSMN1; SMN2
SCHEMBL11330542 0.85 TSHR (0.51) TSHRHTR2AHTR2CHTR2BSMN1; SMN2
SCHEMBL1305946 0.85 TSHR (0.69) TSHRHTR2AHTR2CHTR2BSMN1; SMN2
SCHEMBL11330573 0.85 TSHR (0.51) TSHRHTR2AHTR2CHTR2BSMN1; SMN2
SCHEMBL8505592 0.82 TSHR (0.74) TSHRHTR2AHTR2CHTR2BSMN1; SMN2
SCHEMBL12718928 0.82 TSHR (0.74) TSHRHTR2AHTR2CHTR2BSMN1; SMN2
SCHEMBL1117051 0.81 TSHR (0.44) TSHRHTR2AHTR2CHTR2BSMN1; SMN2
SCHEMBL11342743 0.81 HPGD (0.50) TSHRHTR2AHTR2CHTR2BSMN1; SMN2
SCHEMBL11340856 0.80 SMN1; SMN2 (0.51) TSHRHTR2AHTR2CHTR2BSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2316829-A1 Heterocyclic derivatives as modulators of ion channels Vertex Pharmaceuticals Incorporated (US) 2011-05-04 EP disclosed
EP-2308872-A1 Heterocyclic derivatives as modulators of ion channels Vertex Pharmaceuticals Incorporated (US) 2011-04-13 EP disclosed